Free Trial

The Beauty Health Company (NASDAQ:SKIN) Shares Purchased by Millennium Management LLC

Beauty Health logo with Medical background

Millennium Management LLC boosted its holdings in shares of The Beauty Health Company (NASDAQ:SKIN - Free Report) by 30.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,118,970 shares of the company's stock after buying an additional 730,647 shares during the quarter. Millennium Management LLC owned 2.51% of Beauty Health worth $4,959,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Bridgeway Capital Management LLC increased its holdings in shares of Beauty Health by 13.6% during the 4th quarter. Bridgeway Capital Management LLC now owns 1,211,600 shares of the company's stock valued at $1,926,000 after purchasing an additional 145,000 shares in the last quarter. BNP Paribas Financial Markets purchased a new position in shares of Beauty Health during the 4th quarter valued at approximately $129,000. Northern Trust Corp increased its holdings in shares of Beauty Health by 6.8% during the 4th quarter. Northern Trust Corp now owns 663,752 shares of the company's stock valued at $1,055,000 after purchasing an additional 42,078 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Beauty Health by 19.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 114,147 shares of the company's stock valued at $182,000 after purchasing an additional 18,400 shares in the last quarter. Finally, Mirabella Financial Services LLP purchased a new position in shares of Beauty Health during the 4th quarter valued at approximately $14,292,000. 93.26% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group cut their target price on shares of Beauty Health from $1.50 to $1.25 and set a "hold" rating for the company in a report on Monday, May 5th.

View Our Latest Stock Report on Beauty Health

Beauty Health Price Performance

Beauty Health stock traded down $0.03 during trading on Monday, reaching $1.60. The company had a trading volume of 641,303 shares, compared to its average volume of 1,041,455. The firm's 50-day simple moving average is $1.28 and its 200 day simple moving average is $1.44. The Beauty Health Company has a 1-year low of $0.78 and a 1-year high of $2.26. The firm has a market capitalization of $201.59 million, a PE ratio of -3.81 and a beta of 0.88. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56.

Beauty Health (NASDAQ:SKIN - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.05. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. The firm had revenue of $69.60 million for the quarter, compared to analysts' expectations of $63.88 million. As a group, equities research analysts anticipate that The Beauty Health Company will post -0.25 earnings per share for the current fiscal year.

Beauty Health Company Profile

(Free Report)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.

Featured Stories

Institutional Ownership by Quarter for Beauty Health (NASDAQ:SKIN)

Should You Invest $1,000 in Beauty Health Right Now?

Before you consider Beauty Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beauty Health wasn't on the list.

While Beauty Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines